Search Criteria : United States of America Jersey City
Sep 11, 2020 | CE Credits 7 | USD $299 | Jersey City, New Jersey
Achieving Superb Results with Everyday Direct Procedures is organized by Ultradent Products Inc and will be held on Sep 11, 2020 at Jersey City, New Jersey, United States of America. Accreditation: 7 CE Credits Description: Today’s dental offices require a myriad of materials and techniques. These procedures demand time and practice to allow dentists to become proficient enough to provide great patient care. New technologies have emerged that will help close the gap between early materials and the newest generation of products. This course will show evidence-based data, case presentations, methods of treating various procedures, and ways to standardize and simplify processes to ensure predictability and superb outcomes! Objectives: • How to simplify routine techniques to save time and reduce overhead • How to handle difficult situations such as discolored teeth, subgingival margins, and isolation problems • How to eliminate sensitivity and reduce polymerization shrinkage at the margins of your composites, thus increasing the longevity of your restorations • How to achieve great results using tissue management techniques, great matrix procedures, and simple polishing methods • Hands-on techniques to produce great direct results in numerous procedures • Take-home tips and skills that you can utilize right away in your office to make your practice and life easier Additional details will be posted as soon as information is available.
Oct 05 - 06, 2020 | USD $350 | Jersey City, New Jersey
21st International Conference on Alzheimer’s Drug Discovery is organized by Alzheimer's Drug Discovery Foundation (ADDF) and will be held from Oct 05 - 06, 2020 at Hyatt Regency Jersey City on the Hudson, Jersey City, New Jersey, United States of America. Description: This annual conference will showcase the innovative approaches of ADDF funded scientists and their newest results. Attendees will have the opportunity for networking and partnering discussions. The conference offers a wide range of registration options (including early-bird rates) for researchers from the nonprofit, academic, biotech, and pharma sectors. Audience: The 2019 edition of this conference attracted close to 130 attendees from around the world. Attendees included: • Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases and CNS • Business development and licensing professionals • Alliance management professionals • Venture capitalists and other investors • Graduate students, PhD candidates and post-doctoral fellows. Focus: The purpose for this annual Alzheimer’s Drug Discovery Foundation conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging. Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders. Objectives: • Highlight scientific progress on drug development programs aimed at treating Alzheimer’s disease and related dementias. • Increase networking opportunities for scientists to share information and resources. • Foster interdisciplinary and public-private partnerships and alliances.
Oct 16 - 17, 2020 | CME 11 | USD $150 | Jersey City, New Jersey
GI and Liver Association of the Americas (GALA) Tri-State Conference is organized by GI and Liver Association of the Americas (GALA) and will be held from Oct 16 - 17, 2020 at Hyatt Regency Jersey City on the Hudson, Jersey City, New Jersey, United States of America. Target Audience: Gastroenterologists, hepatologists, internists, family practitioners, surgeons, physician assistants, nurse practitioners, fellows/residents in training, registered nurses, and other healthcare professionals with an interest in GI and liver diseases. Accreditation: The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ANCC Accreditation The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. A maximum of 10.6 contact hours may be earned for successful completion of this activity. ABIM Maintenance of Certification (MOC) Points Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Goal Statement: This CME conference is guaranteed to provide a comprehensive update on GI and liver diseases from renowned faculty. The 1.5-day conference will have a strong focus on viral hepatitis, NAFLD/NASH, primary biliary cirrhosis, drug-induced liver injury, complications of portal hypertension, including hepatic encephalopathy and thrombocytopenia, hepatocellular carcinoma, GERD, chronic pancreatitis, fecal incontinence, and irritable bowel syndrome. Statement of Need / Program Overview: Digestive diseases include a wide spectrum of disorders affecting the oropharynx and alimentary canal, liver and biliary system, and pancreas. Chronic GI disorders are common in the US, and the prevalence is increasing. Considerable overlap can be found in the symptoms of serious GI diseases and the symptoms of benign or functional GI diseases. Noninvasive diagnostic tests, sensible clinical evaluation plans, and a clear understanding of disease progression will enhance patient assessment/management and identify the right patients for referral to GI specialists. For patients with a confirmed diagnosis of a chronic GI disorder, advances in the understanding of the clinical impact of evolving treatment options offer new choices for managing these conditions. The conference format will consist of lectures, Q&A/panel discussions, and parallel breakout sessions for in-depth discussions of high-interest topics. CME Learning Objectives: Upon completion of this conference, participants should be better able to: • Describe evolving patient management and treatment strategies for CLD and GI disorders • Integrate significant advances in therapeutic and diagnostic modalities into clinical practice • Apply the latest clinical research, including future therapies and their role in the context of the current clinical paradigm